One crucial way in which tumor cells differ from their normal cellular counterparts is in their ability to grow independently of growth factors. These growth factors, their concentrations and availability, provide a means for the organism to control the growth of its component cells. Tumor cells, by no longer requiring growth factors, are thus able to proliferate without control, having escaped normal constraints on growth. The same transforming oncogene (v-ras) will rapidly render cells of very different lineages independent of their respective growth factors. For example, fibroblasts become independent of platelet-derived growth factor, endothelial cells independent of endothelial cell growth factor, mast cells independent of interleukin 3, and B and T lymphocytes independent of antigen/BSF-1 and antigen/IL-2, respectively. The mechanisms by which transformed cells become autonomous of growth factors are not entirely clear, but it is apparent that this independence is critical to the unchecked growth of the tumor. A recent discovery is that certain viral oncogenes control the expression of growth-related proto-oncogenes in the host cell. It is hypothesized that this activity may be related to the ability of the viral oncogene to render the infected cells independent of the need for growth factors. Furthermore, this activity of the oncogenes allows creation of viable cellular """"""""mutants"""""""" with blocks in growth factor signal transduction, providing a powerful tool to the study of growth factor action in normal and transformed cells. The approach proposed then is to use this action of viral oncogenes to begin to dissect out the element sof at least one important and common growth factor signal transduction is intrinsic to the oncogenic activities of v-ras and other viral oncogenes. Finally, this system will be used to explore the more complex growth factor, lymphokine and antigen interactions with lymphoid cells, and the way in which these growth factor requirements and responses change after transformation.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Research Project (R01)
Project #
7R01CA050459-03
Application #
3194956
Study Section
Cellular Biology and Physiology Subcommittee 1 (CBY)
Project Start
1990-05-01
Project End
1995-04-30
Budget Start
1991-10-01
Budget End
1992-04-30
Support Year
3
Fiscal Year
1991
Total Cost
Indirect Cost
Name
Boston University
Department
Type
Schools of Medicine
DUNS #
604483045
City
Boston
State
MA
Country
United States
Zip Code
02118
van de Mark, Karyn; Chen, James S; Steliou, Kosta et al. (2003) Alpha-lipoic acid induces p27Kip-dependent cell cycle arrest in non-transformed cell lines and apoptosis in tumor cell lines. J Cell Physiol 194:325-40
Guo, Ning; Faller, Douglas V; Vaziri, Cyrus (2002) Carcinogen-induced S-phase arrest is Chk1 mediated and caffeine sensitive. Cell Growth Differ 13:77-86
Stice, Ligaya L; Forman, Lora W; Hahn, Chang S et al. (2002) Desensitization of the PDGFbeta receptor by modulation of the cytoskeleton: the role of p21(Ras) and Rho family GTPases. Exp Cell Res 275:17-30
Ma, Peihong; Magut, Maureen; Faller, Douglas V et al. (2002) The role of Ras in T lymphocyte activation. Cell Signal 14:849-59
Lynch, E M; Moreland, R B; Ginis, I et al. (2001) Hypoxia-activated ligand HAL-1/13 is lupus autoantigen Ku80 and mediates lymphoid cell adhesion in vitro. Am J Physiol Cell Physiol 280:C897-911
Demary, K; Wong, L; Liou, J S et al. (2001) Redox control of retinoic acid receptor activity: a novel mechanism for retinoic acid resistance in melanoma cells. Endocrinology 142:2600-5
Chen, C Y; Juo, P; Liou, J S et al. (2001) The recruitment of Fas-associated death domain/caspase-8 in Ras-induced apoptosis. Cell Growth Differ 12:297-306
Ghosh, S K; Roy-Burman, P; Faller, D V (2000) Long terminal repeat regions from exogenous but not endogenous feline leukemia viruses transactivate cellular gene expression. J Virol 74:9742-8
Denis, G V; Vaziri, C; Guo, N et al. (2000) RING3 kinase transactivates promoters of cell cycle regulatory genes through E2F. Cell Growth Differ 11:417-24
Guo, N; Faller, D V; Denis, G V (2000) Activation-induced nuclear translocation of RING3. J Cell Sci 113 ( Pt 17):3085-91

Showing the most recent 10 out of 23 publications